Spotlighting a One-Stop Service to ADCs & Linker-Payloads with a Strong US Presence

• Harnessing site integration to promote rapid development and delivery of ADCs and other bioconjugates modalities with compressed timelines 
• Breaking down track record in new modalities such as bispecific and dual payload ADCs 
• Contextualizing New Jersey site (J-Star Research) to serve as the center of synthetic innovation in HPAPI research

Speakers:

Nori Ikemoto

Senior Director, Process R&D

Porton Chemicals